Annual Drug Patent Expirations for GAVRETO
Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixty patent family members in thirty-four countries.
The generic ingredient in GAVRETO is pralsetinib. One supplier is listed for this compound. Additional details are available on the pralsetinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
